BeautyLaw

Galderma Agrees to a $990,000 Settlement Over Alleged Benzene Contamination in Differin Acne Products

Galderma Laboratories has agreed to a $990,000 settlement to resolve a class action lawsuit alleging that certain Differin branded benzoyl peroxide acne treatments were potentially contaminated with benzene, a well known carcinogen.

Galderma Agrees to a $990,000 Settlement Over Alleged Benzene Contamination in Differin Acne Products
BeautyLaw

Galderma Agrees to a $990,000 Settlement Over Alleged Benzene Contamination in Differin Acne Products

Credit: Galderma

Galderma Laboratories has agreed to a $990,000 settlement to resolve a class action lawsuit alleging that certain Differin branded benzoyl peroxide acne treatments were potentially contaminated with benzene, a well known carcinogen. The settlement received preliminary court approval on February 19, 2026, and covers consumers who purchased the affected products in the United States between January 1, 2020, and February 19, 2026.

RetailBoss

RetailBoss is an independent global news publication and business insights platform built for executives, founders, operators, analysts, marketers, investors, and brand leaders. Our reporting covers the retail shifts across luxury, fashion, beauty, technology and marketing strategy.

Since
2011
Audience
50 Million+
Coverage
Global Markets
Our editorial stance

We prioritize news value, evidence, attribution, and practical relevance to retail decision-makers. Sponsored work is identified, and editorial coverage is kept distinct from commercial partnerships.

More from Beauty

Recommended Articles

RetailBoss Daily

Sign up for RetailBoss Daily Newsletter

Start the day with the retail news, exclusive context, and key industry events that matter—delivered directly to your inbox.

RETAILBOSS DISCOVERY

What are you looking for?

Search the stories, companies and ideas shaping retail.

Start exploring

Esc to close · Tab to navigateOpen full results →